Search images on Google      Product Monograph

Active Ingredients:

• zoledronic acid (zoledronic acid monohydrate), 4 MG/5 ML

DIN: 02415186

Dosage Form(s): SOLUTION

Route(s) of Administration: INTRAVENOUS

Description: TO BE DILUTED BEFORE USE. FOR IV INFUSION. 5ML SINGLE DOSE VIAL.

Schedule: Prescription

Company: TARO PHARMACEUTICALS INC  –  official site

ATC:

• M05 - DRUGS FOR TREATMENT OF BONE DISEASES (ATC, WHO, Wiki)
• M05B - DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION (ATC, WHO)
• M05BA - Bisphosphonates (ATC, WHO)
• M05BA08 - ZOLEDRONIC ACID (WHO)

Reference brand drug: Aclasta

Packaging:

• Package size unit: No information
• Package type: No information
• Package size: No information
• Product information: 6* 5ML(VIAL)

 

External Links for Taro-Zoledronic Acid Concentrate:

Search on Google

• Taro-Zoledronic Acid Concentrate side effects
• Taro-Zoledronic Acid Concentrate dosage
• zoledronic acid side effects
• zoledronic acid dosage

Taro Pharmaceuticals Inc

Go to Taro website to see drug product details. Sometimes you can find taro-zoledronic acid concentrate photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.